Spots Global Cancer Trial Database for cancer of the head and neck
Every month we try and update this database with for cancer of the head and neck cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of the Role of Prostaglandins in Radiation-induced Mucositis | NCT01252498 | Cancer of the H... Radiotherapy | 18 Years - | University of Vermont | ||
| An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck | NCT00684385 | Non Small Cell ... Cancer of the H... | ZD1839 | 18 Years - 130 Years | AstraZeneca | |
| Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer | NCT04444869 | Cancer of the H... Oropharynx Canc... HPV Positive Or... Throat Carcinom... | Cisplatin injec... | 18 Years - | University of Missouri-Columbia | |
| A Web-Based Multimedia Intervention for Head and Neck Cancer Patients | NCT02442336 | Cancer of the H... | My Journey AHea... | 18 Years - | Fox Chase Cancer Center | |
| Fluorescence Imaging in Head and Neck Cancer | NCT03297957 | Head and Neck C... Cancer of the H... | Hands-free gogg... | 18 Years - | Washington University School of Medicine | |
| Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck | NCT00474825 | Carcinoma, Squa... Cancer of the H... | Hyperbaric Oxyg... Hyperbaric Oxyg... Hyperbaric oxyg... Hyperbaric oxyg... | 18 Years - 70 Years | National Baromedical Services | |
| Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation | NCT00716157 | Cancer of the H... Cancer of the L... Cancer of the E... Gastro-esophage... | 18 Years - | Thomas Jefferson University | ||
| IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma | NCT00242749 | Cancer of Head ... | Gefitinib, Cisp... | 18 Years - 70 Years | AstraZeneca | |
| Study in Advanced Solid Tumors | NCT01099358 | Solid Tumor | Cetuximab Cisplatin 5 - Fluorouraci... | 18 Years - | Eli Lilly and Company | |
| Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer | NCT00140556 | Head and Neck C... Pharynx Cancer | Chemoradiothera... Cisplatin Bevacizumab Erlotinib | 18 Years - | Duke University | |
| Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC | NCT04470024 | Cancer of the H... | INCAGN01876 INCMGA00012 DPV-001 | 18 Years - | Providence Health & Services | |
| PET With [18F]HX4 in Head and Neck Cancer | NCT01347281 | Cancer of the H... | Injection of [1... | 18 Years - 100 Years | Maastricht Radiation Oncology | |
| Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer | NCT01370876 | Cancer of the H... Neoplasms, Head... | Oxaliplatin | 20 Years - 75 Years | Nang Kuang Pharmaceutical Co., Ltd. | |
| Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer | NCT04865731 | Cancer of the H... | Dermaprazole Aquaphor | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck | NCT00474825 | Carcinoma, Squa... Cancer of the H... | Hyperbaric Oxyg... Hyperbaric Oxyg... Hyperbaric oxyg... Hyperbaric oxyg... | 18 Years - 70 Years | National Baromedical Services | |
| Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma | NCT02270814 | Head and Neck C... Head and Neck S... Cancer of the H... | nab-paclitaxel Cisplatin Carboplatin Cetuximab | 18 Years - | Washington University School of Medicine | |
| Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT05678348 | Head and Neck C... Cancer of the H... | Pyrimethamine | 18 Years - | Washington University School of Medicine | |
| A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer | NCT01283334 | Head and Neck N... Cancer of the H... | Carboplatin Cetuximab RAD001 | 18 Years - | Emory University | |
| Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer | NCT00256295 | Cancer of the H... | Gemcitabine Oxaliplatin | 18 Years - | University of California, Irvine | |
| Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation | NCT00716157 | Cancer of the H... Cancer of the L... Cancer of the E... Gastro-esophage... | 18 Years - | Thomas Jefferson University | ||
| A Web-Based Multimedia Intervention for Head and Neck Cancer Patients | NCT02442336 | Cancer of the H... | My Journey AHea... | 18 Years - | Fox Chase Cancer Center | |
| Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck | NCT00180921 | Cancer of the H... Carcinoma, Aden... | Imatinib | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| PET With [18F]HX4 in Head and Neck Cancer | NCT01347281 | Cancer of the H... | Injection of [1... | 18 Years - 100 Years | Maastricht Radiation Oncology | |
| IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma | NCT00242749 | Cancer of Head ... | Gefitinib, Cisp... | 18 Years - 70 Years | AstraZeneca | |
| Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma | NCT02270814 | Head and Neck C... Head and Neck S... Cancer of the H... | nab-paclitaxel Cisplatin Carboplatin Cetuximab | 18 Years - | Washington University School of Medicine | |
| DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC | NCT00496652 | Cancer of the H... | Radiotherapy Zalutumumab | 18 Years - | Danish Head and Neck Cancer Group | |
| Radiotherapy With Humidification in Head And Neck Cancer | NCT01917942 | Cancer of the H... | Humidification Standard of Car... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Radiotherapy With Humidification in Head And Neck Cancer | NCT01917942 | Cancer of the H... | Humidification Standard of Car... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) | NCT02573493 | Squamous Cell C... Carcinoma, Squa... Cancer of Head ... Cancer of the H... Head and Neck C... Neoplasms, Head... | nab-Paclitaxel Cisplatin Cetuximab Intensity-Modul... | 18 Years - | Washington University School of Medicine | |
| An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck | NCT00684385 | Non Small Cell ... Cancer of the H... | ZD1839 | 18 Years - 130 Years | AstraZeneca | |
| Fluorescence Imaging in Head and Neck Cancer | NCT03297957 | Head and Neck C... Cancer of the H... | Hands-free gogg... | 18 Years - | Washington University School of Medicine | |
| Study in Advanced Solid Tumors | NCT01099358 | Solid Tumor | Cetuximab Cisplatin 5 - Fluorouraci... | 18 Years - | Eli Lilly and Company | |
| Real-time Activity Monitoring to Prevent Admissions During RadioTherapy | NCT03102229 | Cancer of the H... Cancer of Lung Cancer of Esoph... Cancer of Stoma... | Enhanced Suppor... Enhanced Suppor... | 18 Years - | Albert Einstein College of Medicine | |
| Real-time Activity Monitoring to Prevent Admissions During RadioTherapy | NCT03102229 | Cancer of the H... Cancer of Lung Cancer of Esoph... Cancer of Stoma... | Enhanced Suppor... Enhanced Suppor... | 18 Years - | Albert Einstein College of Medicine | |
| Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer | NCT00256295 | Cancer of the H... | Gemcitabine Oxaliplatin | 18 Years - | University of California, Irvine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
